Venetoclax Effectiveness, Safety, and Treatment Patterns in Chronic Lymphocytic Leukemia Patients: Results from the CLL Collaborative Study of Real-World Evidence (CORE)

被引：0
|
作者：
Zheng, Dandan
Sail, Kavita
Roeker, Lindsey E.
Manzoor, Beenish S.
Tuncer, Hande H.
Allan, John N.
Ujjani, Chaitra S.
Barr, Paul M.
Brown, Jennifer R.
Eyre, Toby A.
Skarbnik, Alan
Bannerji, Rajat
Eichhorst, Barbara
Brander, Danielle M.
Sharmokh, Simon
Jiang, Daniel Dingfeng
Pena, German
Kamalakar, Rajesh
Emechebe, Nnadozie
Pivneva, Irina
Burne, Rebecca
Guerin, Annie
Davids, Matthew S.
Mato, Anthony
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134676
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Treatment Effectiveness with Venetoclax-Based Therapy after Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study
    Ghosh, Nilanjan
    Lamanna, Nicole
    Eyre, Toby A.
    Coombs, Catherine C.
    Manzoor, Beenish S.
    Brown, Jennifer R.
    Tuncer, Hande H.
    Ujjani, Chaitra S.
    Leslie, Lori A.
    Roeker, Lindsey E.
    Davids, Matthew S.
    Rhodes, Joanna M.
    Skarbnik, Alan
    Emechebe, Nnadozie
    Fleury, Isabelle
    Hill, Brian T.
    Fox, Christopher P.
    Barr, Paul M.
    Jawaid, Dureshahwar
    Sinai, Wendy J.
    Pearson, Laurie K.
    Lansigan, Frederick
    Choi, Yun
    Jensen, Christopher E.
    Schuster, Stephen J.
    Kennard, Kaitlin
    Pivneva, Irina
    Watson, Talissa
    Guerin, Annie
    Shadman, Mazyar
    BLOOD, 2023, 142
  • [32] Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study
    Ghosh, Nilanjan
    Eyre, Toby A.
    Brown, Jennifer R.
    Lamanna, Nicole
    Manzoor, Beenish S.
    Coombs, Catherine C.
    Tuncer, Hande H.
    Ujjani, Chaitra
    Leslie, Lori A.
    Roeker, Lindsey E.
    Davids, Matthew S.
    Rhodes, Joanna M.
    Skarbnik, Alan P.
    Sinai, Wendy
    Fleury, Isabelle
    Hill, Brian T.
    Martinez-Calle, Nicolas
    Barr, Paul M.
    Jawaid, Dureshahwar
    Emechebe, Nnadozie
    Pearson, Laurie
    Lansigan, Frederick
    Choi, Yun
    Jensen, Christopher E.
    Fakhri, Bita
    Stephens, Deborah M.
    Marx, Steven E.
    Schuster, Stephen J.
    Coyle, Michael
    Pivneva, Irina
    Watson, Talissa
    Guerin, Annie
    Shadman, Mazyar
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (03) : 511 - 515
  • [33] Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study
    Mauro, Francesca Romana
    Scalzulli, Potito Rosario
    Scarfo, Lydia
    Minoia, Carla
    Murru, Roberta
    Sportoletti, Paolo
    Frigeri, Ferdinando
    Albano, Francesco
    Di Renzo, Nicola
    Sanna, Alessandro
    Laurenti, Luca
    Massaia, Massimo
    Cassin, Ramona
    Coscia, Marta
    Patti, Caterina
    Pennese, Elsa
    Tafuri, Agostino
    Chiarenza, Annalisa
    Galieni, Piero
    Perbellini, Omar
    Selleri, Carmine
    Califano, Catello
    Ferrara, Felicetto
    Cuneo, Antonio
    Murineddu, Marco
    Palumbo, Gaetano
    Scortechini, Ilaria
    Tedeschi, Alessandra
    Trentin, Livio
    Varettoni, Marzia
    Pane, Fabrizio
    Liberati, Anna Marina
    Merli, Francesco
    Morello, Lucia
    Musuraca, Gerardo
    Tani, Monica
    Ibatici, Adalberto
    Regazzoni, Giulia
    Di Candia, Michele
    Palma, Maria
    Arienti, Danilo
    Molica, Stefano
    CANCERS, 2024, 16 (06)
  • [34] Demographics, treatment patterns, safety, and real-world effectiveness in patients aged 70 years and over with chronic lymphocytic leukemia receiving bendamustine with or without rituximab: a retrospective study
    Kolibaba, Kathryn S.
    Sterchele, James A.
    Joshi, Avani D.
    Forsyth, Michael
    Alwon, Erin
    Beygi, Hooman
    Kennealey, Gerard T.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (03) : 157 - 171
  • [35] Preliminary Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL)
    Lampson, Benjamin L.
    Tyekucheva, Svitlana
    Crombie, Jennifer L.
    Kim, Austin I.
    Merryman, Reid W.
    Lowney, Jessica
    Montegaard, Josie
    Patterson, Victoria
    Jacobson, Caron A.
    Jacobsen, Eric D.
    LaCasce, Ann S.
    Arnason, Jon E.
    Armand, Philippe
    Fisher, David C.
    Brown, Jennifer R.
    Davids, Matthew S.
    BLOOD, 2019, 134
  • [36] Impact of Ibrutinib in Quality of Life (QoL) in Patients with Chronic Lymphocytic Leukemia (CLL): Preliminary Results of Real-World Experience
    Mela Osorio, Maria Jose
    Pavlovsky, Carolina
    Pavlovsky, Astrid
    Fernandez, Isolda
    Sackmann Massa, Federico
    Ferrari, Luciana
    Juni, Mariana
    Riddick, Maximiliano
    Pavlovsky, Miguel A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S218 - S219
  • [37] Real-world evidence of impact of atrial fibrillation (AF) on clinical and economic outcomes in patients with chronic lymphocytic leukemia (CLL).
    Yang, Keri
    Liu, Tom
    Tang, Boxiong
    Chanan-Khan, Asher
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18729 - E18729
  • [38] Treatment with idelalisib in patients with chronic lymphocytic leukemia - real world data from the registry of the German CLL Study Group
    von Tresckow, Julia
    Heyl, Nikola
    Robrecht, Sandra
    Giza, Adam
    Aldaoud, Ali
    Schlag, Rudolf
    Klausmann, Martine
    Linde, Hartmut
    Stein, Wolfgang
    Schwarzer, Andreas
    Fischer, Kirsten
    Cramer, Paula
    Eichhorst, Barbara
    Hallek, Michael
    Fink, Anna Maria
    ANNALS OF HEMATOLOGY, 2023, 102 (11) : 3083 - 3090
  • [39] Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group
    Julia von Tresckow
    Nikola Heyl
    Sandra Robrecht
    Adam Giza
    Ali Aldaoud
    Rudolf Schlag
    Martine Klausmann
    Hartmut Linde
    Wolfgang Stein
    Andreas Schwarzer
    Kirsten Fischer
    Paula Cramer
    Barbara Eichhorst
    Michael Hallek
    Anna Maria Fink
    Annals of Hematology, 2023, 102 : 3083 - 3090
  • [40] A Real-World Study of Zanubrutinib Treatment in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Zhu, Huayuan
    Xia, Yi
    Miao, Yi
    Qin, Shuchao
    Wu, Wei
    Qiu, Tonglu
    Wang, Li
    Fan, Lei
    Xu, Wei
    Li, Jianyong
    BLOOD, 2023, 142
12345